The Week In Cannabis: Trulieve’s $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More
In a week of big M&A news and mixed earnings reports, cannabis stocks traded mostly down.
Trulieve Cannabis Hits $193.8M In Q1 Revenue, 13th Consecutive Profitable Quarter Following Harvest Merger
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) reported Thursday its financial results for the first quarter of 2021.